M&A Deal Summary

Elysian Capital Acquires The Landscape Group

On March 20, 2008, private equity firm Elysian Capital acquired business services company The Landscape Group for 7M GBP

Acquisition Highlights
  • This is Elysian Capital’s 1st transaction in the Business Services sector.
  • This is Elysian Capital’s 0th largest (disclosed) transaction.
  • This is Elysian Capital’s 1st transaction in the United Kingdom.
Investment Fate
  • The Landscape Group was sold to a strategic buyer in 2015.

M&A Deal Summary

Date 2008-03-20
Target The Landscape Group
Sector Business Services
Buyer(s) Elysian Capital
Deal Type Buyout (LBO, MBO, MBI)
Deal Value 7M GBP

Target

The Landscape Group

Allesley, United Kingdom
The Landscape Group Ltd. is a independent provider of landscape maintenance, street cleansing and horticultural construction services to the public and private sector.

Search 199,847 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Elysian Capital

London, United Kingdom

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2007
PE ASSETS 700M GBP
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Elysian Capital LLP is an independent private equity firm that targets management buyouts of growing, profitable businesses throughout the UK. Elysian focuses on lower mid-market companies valued between £20 and £100 million. Sectors of interest include healthcare, local and central government, consumer/retail, utilities/renewable and financial/support services. Elysian Capital LLP was formed in 2007 and is based in London.


DEAL STATS #
Overall 1 of 25
Sector (Business Services) 1 of 6
Type (Buyout (LBO, MBO, MBI)) 1 of 16
Country (United Kingdom) 1 of 23
Year (2008) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-05-06 Vertical Pharma Resources

West Molesey, United Kingdom

Vertical Pharma Resources Ltd. (dba Integrated Pharmaceutical Services), manufactures and imports off label unlicensed specials and named patient medicines. The company offers veterinary and dental products, acute/temporary and chronic drugs, clinical trials comparator and orphan drugs, and obsolete/discontinued lines and alternative branded/generic medicines.

Buy -